Efficacy of ADCON-T/N after primary flexor tendon repair in zone II: A controlled clinical trial

A. Golash, A. Kay, J. G. Wagner, F. Peck, J. S. Watson, V. C. Lees

    Research output: Contribution to journalArticlepeer-review

    Abstract

    A prospective double-blind, randomized, controlled clinical trial was conducted to assess the use of ADCON-T/N after flexor tendon repair in Zone II. Forty-five patients with 82 flexor tendon repairs in 50 digits completed the study. ADCON-T/N was injected into the tendon sheath after tenorrhaphy in the experimental group while the control group was not treated with ADCON-T/N. ADCON-T/N had no statistically significant effect on total active motion at 3,6 and 12 months but the time taken to achieve the final range of motion was significantly shorter in treated patients. ADCON-treated patients had a higher rupture rate but this was not significant.
    Original languageEnglish
    Pages (from-to)113-115
    Number of pages2
    JournalJournal of Hand Surgery (European Volume)
    Volume28
    Issue number2
    DOIs
    Publication statusPublished - Apr 2003

    Fingerprint

    Dive into the research topics of 'Efficacy of ADCON-T/N after primary flexor tendon repair in zone II: A controlled clinical trial'. Together they form a unique fingerprint.

    Cite this